The HCPLive conference coverage page features articles, videos, and expert-led live coverage from major medical meetings throughout the year.
Huntington's Disease Can Affect the Heart
Huntington's Disease (HD) is an autosomal dominant progressive neurodegenerative disorder. In addition to the central nervous system disturbance the ailment causes, there is increasing evidence the genetic abnormality also affects peripheral organs and tissues.
Cooling Device May Work for Multiple Sclerosis, but Patients Resisted
Patients with multiple sclerosis (MS) often have sensitivity to heat that worsens their symptoms. In earlier studies with MS patients, a device system that cools body temperature by chilling one palm proved useful in helping them walk faster and longer. But patients need to be motivated to use it successfully.
Liver Meeting Draws 11,000 to Vienna
An estimated 11,000 attendees from 105 countries are converging in Vienna, Austria for the 50th International Liver Congress, hosted by the European Association for the Study of the Liver (ILC/EASL). Some 200 journalists -- including a team from MD Magazine--are on hand to report the news. Eagerly awaited trials include those of two drugs that show promise for treating a common liver disease associated with obesity, known medically as non-alcoholic steatohepatitis (NASH) and its precursor non-alcoholic fatty liver disease (NAFLD).
Extending Natalizumab's Use Without Increasing Risk to MS Patients
A lot is known about the benefits of Natalizumab in the treatment of MS patients, but there is also a known risk of patients developing progressive multifocal leukoencephalopathy. Finding a balance between the two conditions was the focus of recent research.
Aptiom Shows Strong Results as Epilepsy Monotherapy
Fred Grossman, DO, FAPA, who serves as the head of Global Clinical Development and Medical Affairs at Sunovion Pharmaceuticals, discusses recent study results that indicated Aptiom (eslicarbazepine acetate), already approved as adjunct therapy for partial-onset seizures, may be effective as a monotherapy for patients with epilepsy.
Course of Progressive Familial Intrahepatic Cholestasis II Varies
Children who develop progressive familial intrahepatic cholestasis Type II (PFIC-II) may get better-at least for a while-without getting a liver transplant. But children borne with the condition do not, a team from Belgium found. Bile salt export pump plays a key role.
Age Hurts Motor Response Inhibition
April 19th 2015As healthy adults age their motor response inhibition may become impaired, according to Ali Shoraka, MD, a Researcher Coordinator at the University of Florida in Gainesville, FL. The study is due to be presented in a poster session on Apr. 20 at the American Academy of Neurology meeting in Washington, DC.
Abnormal Eating and Sucrose Preference in Dementia
April 19th 2015While abnormal eating behaviors are recognized in behavioral frontotemportal dementia (bvFTD) patients, not much has been reported has been found on the effects on their metabolic health until recently, according to lead author Rebekah Ahmed, MD. The study is due to be presented in a poster session on Apr. 20 at the American Academy of Neurology meeting in Washington, DC.
Age and Executive Capacity Linked to Auditory Stimuli
April 19th 2015Age and the level of the brain's executive capacity (EC) are connected to the attention that adults give to novel auditory stimuli, according to Kirk Daffner, MD, chief of the division of Cognitive and Behavioral Neurology and director of the Center for Brain/Mind Medicine at Brigham and Women's Hospital in Boston, MA. The findings are set to be presented in a poster session on Apr. 20 at the American Academy of Neurology meeting in Washington, DC.
Recognizing Opsoclonus Myoclonus Syndrome
Since physicians are unlikely to see many opsoclonus myoclonus syndrome patients, a team of researchers from Boston, MA, set out to offer clinical features, diagnostic findings, and recommended treatments for this rare condition that is often a sign of cancer.
Neurology Meeting Underway in Washington
The American Academy of Neurology's 67th annual meeting starts April 18 in Washington, D.C. and neurologists attending are expecting to hear more about marijuana and seizures, a cheaper MS drug, and whether sleep apnea leads to dementia. A team from MD Magazine will be at the conference with daily news reports and video interviews.